These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 32268133)
1. Hepatitis C virus infection and tight junction proteins: The ties that bind. Mailly L; Baumert TF Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133 [TBL] [Abstract][Full Text] [Related]
2. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process. Baktash Y; Madhav A; Coller KE; Randall G Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098 [TBL] [Abstract][Full Text] [Related]
3. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma. Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454 [TBL] [Abstract][Full Text] [Related]
4. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo. Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007 [TBL] [Abstract][Full Text] [Related]
5. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257 [TBL] [Abstract][Full Text] [Related]
6. Effect of cell polarization on hepatitis C virus entry. Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672 [TBL] [Abstract][Full Text] [Related]
7. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778 [TBL] [Abstract][Full Text] [Related]
8. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094 [TBL] [Abstract][Full Text] [Related]
9. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus receptor expression in normal and diseased liver tissue. Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708 [TBL] [Abstract][Full Text] [Related]
11. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163 [TBL] [Abstract][Full Text] [Related]
12. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773 [TBL] [Abstract][Full Text] [Related]
13. Tandem overexpression of five human factors renders murine hepatocytes susceptible to hepatitis C virus. Lv L; Kang Q; Yu X; Gao B; Hu T; Ma P; Zhang Y; Yan F; Xiao J; Deng J; Zhou X; Xu J Acta Virol; 2015 Mar; 59(1):20-6. PubMed ID: 25790047 [TBL] [Abstract][Full Text] [Related]
15. How hepatitis C virus invades hepatocytes: the mystery of viral entry. Zhu YZ; Qian XJ; Zhao P; Qi ZT World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128 [TBL] [Abstract][Full Text] [Related]
16. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation. von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A mBio; 2016 Nov; 7(6):. PubMed ID: 27834208 [TBL] [Abstract][Full Text] [Related]
17. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership. Perrault M; Pécheur EI Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model. Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969 [TBL] [Abstract][Full Text] [Related]
19. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry. Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950 [TBL] [Abstract][Full Text] [Related]
20. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry. Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J J Virol; 2018 May; 92(10):. PubMed ID: 29491159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]